No Cover Image

Book chapter 605 views

Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?

S. Camporesi, Michael McNamee Orcid Logo

The Ethical Challenges of Emerging Medical Technologies, Pages: 395 - 406

Swansea University Author: Michael McNamee Orcid Logo

Full text not available from this repository: check for access using links below.

DOI (Published version): 10.4324/9781003074984-33

Abstract

In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the sim...

Full description

Published in: The Ethical Challenges of Emerging Medical Technologies
ISBN: 978-100010895-8 9781003074984
Published: Routledge 2020
URI: https://cronfa.swan.ac.uk/Record/cronfa55754
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-11-25T10:50:13Z
last_indexed 2021-01-12T04:20:18Z
id cronfa55754
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-01-11T12:33:05.0033684</datestamp><bib-version>v2</bib-version><id>55754</id><entry>2020-11-25</entry><title>Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?</title><swanseaauthors><author><sid>85b0b1623e55d977378622a6aab7ee6e</sid><ORCID>0000-0002-5857-909X</ORCID><firstname>Michael</firstname><surname>McNamee</surname><name>Michael McNamee</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-11-25</date><deptcode>STSC</deptcode><abstract>In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process &#x2018;doping&#x2019;. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself.</abstract><type>Book chapter</type><journal>The Ethical Challenges of Emerging Medical Technologies</journal><volume/><journalNumber/><paginationStart>395</paginationStart><paginationEnd>406</paginationEnd><publisher>Routledge</publisher><placeOfPublication/><isbnPrint>978-100010895-8</isbnPrint><isbnElectronic>9781003074984</isbnElectronic><issnPrint/><issnElectronic/><keywords/><publishedDay>11</publishedDay><publishedMonth>9</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-09-11</publishedDate><doi>10.4324/9781003074984-33</doi><url/><notes>Edited by Arthur L. Caplan, Brendan Parent</notes><college>COLLEGE NANME</college><department>Sport and Exercise Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>STSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-01-11T12:33:05.0033684</lastEdited><Created>2020-11-25T10:48:43.5745250</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences</level></path><authors><author><firstname>S.</firstname><surname>Camporesi</surname><order>1</order></author><author><firstname>Michael</firstname><surname>McNamee</surname><orcid>0000-0002-5857-909X</orcid><order>2</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2021-01-11T12:33:05.0033684 v2 55754 2020-11-25 Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology? 85b0b1623e55d977378622a6aab7ee6e 0000-0002-5857-909X Michael McNamee Michael McNamee true false 2020-11-25 STSC In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process ‘doping’. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself. Book chapter The Ethical Challenges of Emerging Medical Technologies 395 406 Routledge 978-100010895-8 9781003074984 11 9 2020 2020-09-11 10.4324/9781003074984-33 Edited by Arthur L. Caplan, Brendan Parent COLLEGE NANME Sport and Exercise Sciences COLLEGE CODE STSC Swansea University 2021-01-11T12:33:05.0033684 2020-11-25T10:48:43.5745250 Faculty of Science and Engineering School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences S. Camporesi 1 Michael McNamee 0000-0002-5857-909X 2
title Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
spellingShingle Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
Michael McNamee
title_short Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
title_full Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
title_fullStr Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
title_full_unstemmed Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
title_sort Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?
author_id_str_mv 85b0b1623e55d977378622a6aab7ee6e
author_id_fullname_str_mv 85b0b1623e55d977378622a6aab7ee6e_***_Michael McNamee
author Michael McNamee
author2 S. Camporesi
Michael McNamee
format Book chapter
container_title The Ethical Challenges of Emerging Medical Technologies
container_start_page 395
publishDate 2020
institution Swansea University
isbn 978-100010895-8
9781003074984
doi_str_mv 10.4324/9781003074984-33
publisher Routledge
college_str Faculty of Science and Engineering
hierarchytype
hierarchy_top_id facultyofscienceandengineering
hierarchy_top_title Faculty of Science and Engineering
hierarchy_parent_id facultyofscienceandengineering
hierarchy_parent_title Faculty of Science and Engineering
department_str School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences
document_store_str 0
active_str 0
description In this chapter, the authors consider two plausible scenarios in which an individual is seeking treatment with the gene transfer tools to cope better with pain. In the first scenario the individual is a patient; in the second an athlete. The authors employ a comparative strategy to highlight the similarities and dissimilarities between the ethical frameworks used to evaluate the two scenarios, and to reach the conclusions regarding the justifiability of the potential practice. The World Anti-Doping Agency sets out three criteria used in the decision to call a product or process ‘doping’. These pertain to the (potential) performance-enhancing effects; the potential harm to the health; the (potential) health risks. In endurance sports, the use of Vascular Endothelial Growth Factor-gene transfer as an endurance enhancement technology is not merely ethically unjustifiable; it compromises an element essential to the activity itself.
published_date 2020-09-11T04:10:11Z
_version_ 1763753708084002816
score 11.028886

Similar Items